Evidence map›Paper›PMID 37341842›Full record

ArticleJournal of neuro-oncology2023

Martin C Tom, Frank P DiFilippo, Stephen E Jones, John H Suh, Nancy A Obuchowski, Timothy D Smile, Erin S Murphy, Jennifer S Yu, Gene H Barnett, Lilyana Angelov and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Molecular Brain Tumor Imaging Beyond [AJR. American journal of roentgenology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Treatment Options for Brain Metastases.Current treatment options in oncology · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Martin C TomDepartment of Radiation Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. mtom@mdanderson.org.
Frank P DiFilippoDepartment of Nuclear Medicine, Cleveland Clinic, Cleveland, OH, USA.
Stephen E JonesDepartment of Radiology, Cleveland Clinic, Cleveland, OH, USA.
John H SuhDepartment of Radiation Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Nancy A ObuchowskiQuantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Timothy D SmileDepartment of Radiation Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Erin S MurphyDepartment of Radiation Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Jennifer S YuDepartment of Radiation Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Gene H BarnettCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Lilyana AngelovCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Alireza M MohammadiCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Steve S HuangDepartment of Nuclear Medicine, Cleveland Clinic, Cleveland, OH, USA.
Guiyun WuDepartment of Nuclear Medicine, Cleveland Clinic, Cleveland, OH, USA.
Scott JohnsonDepartment of Radiology, Cleveland Clinic, Cleveland, OH, USA.
David M PeereboomCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Glen H J StevensCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Manmeet S AhluwaliaCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Samuel T ChaoDepartment of Radiation Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic · USCase Western Reserve University · USCleveland Clinic Lerner College of Medicine · USThe Neurological Institute · US

Funding

Lerner Research Institute, Cleveland Clinic RPC 326
6 · The paper itself

Abstract

purposeDistinguishing radiation necrosis from tumor progression among patients with brain metastases previously treated with stereotactic radiosurgery represents a common diagnostic challenge. We performed a prospective pilot study to determine whether PET/CT with

methodsAdults with brain metastases previously treated with radiosurgery presenting with a follow-up tumor-protocol MRI brain equivocal for radiation necrosis versus tumor progression underwent an

resultsOf 16 patients imaged from 7/2019 to 11/2020, 15 subjects were evaluable with 20 lesions (radiation necrosis, n = 16; tumor progression, n = 4). Higher SUV

conclusionsIn this prospective pilot study of patients with brain metastases previously treated with radiosurgery presenting with a contemporary MRI brain with a lesion equivocal for radiation necrosis versus tumor progression,

Indexed as

Brain NeoplasmsRadiosurgeryAdultCarboxylic AcidsCyclobutanesHumansNecrosisPilot ProjectsPositron Emission Tomography Computed TomographyProspective StudiesCarboxylic AcidsCyclobutanesfluciclovine F-1818F-fluciclovine PET/CTBrain metastasesRadiation necrosisStereotactic radiosurgeryTumor progression

Identifiers

PMID37341842
OpenAlexW4381469681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.